Skip to main content

Main menu

  • Home
  • Current issue
  • ERJ Early View
  • Past issues
  • Authors/reviewers
    • Instructions for authors
    • Submit a manuscript
    • Open access
    • COVID-19 submission information
    • Peer reviewer login
  • Alerts
  • Podcasts
  • Subscriptions
  • ERS Publications
    • European Respiratory Journal
    • ERJ Open Research
    • European Respiratory Review
    • Breathe
    • ERS Books
    • ERS publications home

User menu

  • Log in
  • Subscribe
  • Contact Us
  • My Cart

Search

  • Advanced search
  • ERS Publications
    • European Respiratory Journal
    • ERJ Open Research
    • European Respiratory Review
    • Breathe
    • ERS Books
    • ERS publications home

Login

European Respiratory Society

Advanced Search

  • Home
  • Current issue
  • ERJ Early View
  • Past issues
  • Authors/reviewers
    • Instructions for authors
    • Submit a manuscript
    • Open access
    • COVID-19 submission information
    • Peer reviewer login
  • Alerts
  • Podcasts
  • Subscriptions

Development and validation of the Capacity of Daily Living during the Morning questionnaire and the Global Chest Symptoms Questionnaire in COPD

M.R. Partridge, M. Miravitlles, E. Ståhl, N. Karlsson, K. Svensson, T. Welte
European Respiratory Journal 2010 36: 96-104; DOI: 10.1183/09031936.00123709
M.R. Partridge
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • For correspondence: m.partridge@imperial.ac.uk
M. Miravitlles
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
E. Ståhl
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
N. Karlsson
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
K. Svensson
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
T. Welte
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • Article
  • Figures & Data
  • Info & Metrics
  • PDF
Loading

Article Information

vol. 36 no. 1 96-104
DOI 
https://doi.org/10.1183/09031936.00123709
PubMed 
19897551

Published By 
European Respiratory Society
Print ISSN 
0903-1936
Online ISSN 
1399-3003
History 
  • Received August 3, 2009
  • Accepted October 23, 2009
  • Published online June 30, 2010.

Article Versions

  • previous version (November 6, 2009 - 05:57).
  • You are viewing the most recent version of this article.
Copyright & Usage 
©ERS 2010

Author Information

  1. M.R. Partridge*,
  2. M. Miravitlles#,
  3. E. Ståhl¶,
  4. N. Karlsson+,
  5. K. Svensson§ and
  6. T. Weltef
  1. *Faculty of Medicine, Imperial College London, NHLI Division at Charing Cross Hospital, London, UK
  2. #Fundacio Clinic, Institut d'Investigations Biomediques August Pi I Sunyer (IDIBAPS), Barcelona, Spain
  3. ¶AstraZeneca R&D
  4. §HEOR Consulting, Lund
  5. +AstraZeneca R&D, Mölndal, Sweden
  6. fDept of Respiratory Medicine, Hannover Medical School, Hannover, Germany
  1. M.R. Partridge, Faculty of Medicine, Imperial College, London, NHLI Division at Charing Cross, Hospital, St Dunstans Road, London W6 8RP, UK E-mail: m.partridge{at}imperial.ac.uk
View Full Text

Article usage

Article usage: November 2009 to April 2022

AbstractFullPdf
Nov 200976070
Dec 200952039
Jan 201089055
Feb 201075041
Mar 201066054
Apr 201053041
May 201033032
Jun 201056133
Jul 201024732148
Aug 20106101852
Sep 20104892362
Oct 20102652040
Nov 20101771927
Dec 20101711826
Jan 20111481117
Feb 20111061725
Mar 20111581624
Apr 20111001335
May 2011731419
Jun 20111301730
Jul 2011741121
Aug 20111001225
Sep 2011117521
Oct 201171822
Nov 201179316
Dec 201164314
Jan 2012603432
Feb 2012523958
Mar 2012904253
Apr 2012581323
May 2012805241
Jun 2012734249
Jul 2012602430
Aug 2012504624
Sep 2012429739
Oct 2012533649
Nov 2012545562
Dec 2012394636
Jan 2013695943
Feb 2013632128
Mar 2013754149
Apr 2013373532
May 2013463347
Jun 2013323633
Jul 2013172432
Aug 2013292517
Sep 2013452623
Oct 2013463442
Nov 2013364138
Dec 2013182930
Jan 2014162820
Feb 2014311626
Mar 2014242421
Apr 2014212221
May 2014221117
Jun 2014181827
Jul 2014262328
Aug 2014311723
Sep 2014152222
Oct 2014202929
Nov 2014182530
Dec 2014151232
Jan 2015271117
Feb 2015192032
Mar 2015161416
Apr 2015232116
May 2015173428
Jun 2015211817
Jul 201524216
Aug 2015172013
Sep 201582720
Oct 201583319
Nov 2015102928
Dec 20155157
Jan 201673231
Feb 201656441
Mar 2016143531
Apr 20163249
May 201641727
Jun 201651921
Jul 201651822
Aug 20165225
Sep 2016103310
Oct 2016102525
Nov 2016172612
Dec 201692112
Jan 201772812
Feb 201733011
Mar 201795121
Apr 201762913
May 201772932
Jun 201743922
Jul 201764515
Aug 201762912
Sep 2017164343
Oct 201785024
Nov 201744520
Dec 20174218
Jan 201833813
Feb 20189295
Mar 201812817
Apr 201804011
May 201813812
Jun 201854419
Jul 201812310
Aug 201802012
Sep 20180275
Oct 201803219
Nov 201846121
Dec 201851711
Jan 201932610
Feb 201932411
Mar 201953213
Apr 201931815
May 20191117
Jun 201961212
Jul 201912117
Aug 201915919
Sep 201959618
Oct 201961627
Nov 20196377
Dec 201922218
Jan 202003312
Feb 202032317
Mar 202041312
Apr 20201254
May 20204153
Jun 202012214
Jul 20200139
Aug 20200178
Sep 202023011
Oct 20203288
Nov 202043012
Dec 20204249
Jan 20210168
Feb 202174711
Mar 202142815
Apr 202162821
May 202122513
Jun 20211155
Jul 20215126
Aug 202152010
Sep 20213175
Oct 202111726
Nov 202121519
Dec 202152518
Jan 2022143220
Feb 202210178
Mar 20228178
Apr 202291917

Altmetrics

PreviousNext
Back to top
View this article with LENS
Vol 36 Issue 1 Table of Contents
European Respiratory Journal: 36 (1)
  • Table of Contents
  • Index by author
Email

Thank you for your interest in spreading the word on European Respiratory Society .

NOTE: We only request your email address so that the person you are recommending the page to knows that you wanted them to see it, and that it is not junk mail. We do not capture any email address.

Enter multiple addresses on separate lines or separate them with commas.
Development and validation of the Capacity of Daily Living during the Morning questionnaire and the Global Chest Symptoms Questionnaire in COPD
(Your Name) has sent you a message from European Respiratory Society
(Your Name) thought you would like to see the European Respiratory Society web site.
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Print
Citation Tools
Development and validation of the Capacity of Daily Living during the Morning questionnaire and the Global Chest Symptoms Questionnaire in COPD
M.R. Partridge, M. Miravitlles, E. Ståhl, N. Karlsson, K. Svensson, T. Welte
European Respiratory Journal Jul 2010, 36 (1) 96-104; DOI: 10.1183/09031936.00123709

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero

Share
Development and validation of the Capacity of Daily Living during the Morning questionnaire and the Global Chest Symptoms Questionnaire in COPD
M.R. Partridge, M. Miravitlles, E. Ståhl, N. Karlsson, K. Svensson, T. Welte
European Respiratory Journal Jul 2010, 36 (1) 96-104; DOI: 10.1183/09031936.00123709
del.icio.us logo Digg logo Reddit logo Technorati logo Twitter logo CiteULike logo Connotea logo Facebook logo Google logo Mendeley logo
Full Text (PDF)

Jump To

  • Article
    • Abstract
    • METHODS
    • RESULTS
    • DISCUSSION
    • Footnotes
    • REFERENCES
  • Figures & Data
  • Info & Metrics
  • PDF

Subjects

  • COPD and smoking
  • Tweet Widget
  • Facebook Like
  • Google Plus One

More in this TOC Section

Original Article

  • Lung volumes and survival in chronic lung allograft dysfunction
  • StO2 during weaning from mechanical ventilation
  • Automated quantification of radiological patterns predicts IPF survival
Show more Original Article

COPD

  • Use of singing for lung health in COPD
  • Response to exercise training and withdrawal in COPD
  • A phase 2a crossover trial in COPD of the bronchodilator navafenterol
Show more COPD

Related Articles

Navigate

  • Home
  • Current issue
  • Archive

About the ERJ

  • Journal information
  • Editorial board
  • Reviewers
  • Press
  • Permissions and reprints
  • Advertising

The European Respiratory Society

  • Society home
  • myERS
  • Privacy policy
  • Accessibility

ERS publications

  • European Respiratory Journal
  • ERJ Open Research
  • European Respiratory Review
  • Breathe
  • ERS books online
  • ERS Bookshop

Help

  • Feedback

For authors

  • Instructions for authors
  • Publication ethics and malpractice
  • Submit a manuscript

For readers

  • Alerts
  • Subjects
  • Podcasts
  • RSS

Subscriptions

  • Accessing the ERS publications

Contact us

European Respiratory Society
442 Glossop Road
Sheffield S10 2PX
United Kingdom
Tel: +44 114 2672860
Email: journals@ersnet.org

ISSN

Print ISSN:  0903-1936
Online ISSN: 1399-3003

Copyright © 2022 by the European Respiratory Society